Intrapartum antibiotics are widely used and may potentially affect bilirubin levels and neurotoxicity in the newborn. The aim of this study was to examine the effect of intrapartum antibiotic exposure on neonatal jaundice. We retrospectively collected data from 972 neonates born to 963 mothers. Five hundred forty-five mothers (56.6%) received intrapartum antibiotics. There were no statistically significant differences in maximum bilirubin level (7.82 ± 3.65 vs 7.63 ± 3.71, P = .43) or need for phototherapy (9 [1.62%] vs 4 [0.94%], P = .52) between exposed and non-exposed newborns. The rate of phototherapy was significantly higher only in the group of infants born to mothers who received broad-spectrum antibiotics at 2 to 3.9 hours prior to delivery (χ2 = 10.453, P = .015) and was not higher in the group of exposure >4 hours, which may represent a short transient effect of antibiotics exposure on bilirubin turnover. Further studies are needed to validate this finding.
Hyperbilirubinemia in term and near-term infants: kernicterus on the rise? [Internet]. Medscape. Published 2022. Accessed March 16, 2023. https://www.medscape.com/viewarticle/497028_3.
2.
Viel-TheriaultIFellDBGrynspanDRedpathSThampiN. The transplacental passage of commonly used intrapartum antibiotics and its impact on the newborn management: a narrative review. Early Hum Dev. 2019;135:6-10.
3.
TapiainenTKoivusaariPBrinkacL, et al. Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants. Sci Rep. 2019;9(1):10635.
4.
AhYKimYKimM, et al. Drug-induced hyperbilirubinemia and the clinical influencing factors. Drug Metab Rev. 2008;40(4):511-537.
5.
NordenCDesforgesJKassE. Hemolytic effect of sulfonamides in patients with erythrocytes deficient in glucose-6-phosphate dehydrogenase. N Engl J Med. 1968;279(1):30-31.
6.
NanduriSPetitSSmelserC, et al. Epidemiology of invasive early-onset and late-onset group b streptococcal disease in the United States, 2006 to 2015. JAMA Pediatr. 2019;173(3):224-233.
7.
LiSHuangJChenZGuoDYaoZYeX. Antibiotic prevention for maternal group B streptococcal colonization on neonatal GBS-related adverse outcomes: a meta-analysis. Front Microbiol. 2017;8:374.
8.
RaoGAMannJRShoaibiA, et al. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med. 2014;12(2):121-127.
9.
LapinBPiorkowskiJOwnbyD, et al. Relationship between prenatal antibiotic use and asthma in at-risk children. Ann Allergy Asthma Immunol. 2015;114(3):203-207.
10.
MetsäläJLundqvistAVirtaLKailaMGisslerMVirtanenS. Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood. Clin Exp Allergy. 2014;45(1):137-145.
11.
JensenETKappelmanMDKimHPRingel-KulkaTDellonES. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57(1):67-71.
12.
MeerausWHPetersenIGilbertR. Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement network. PLoS ONE. 2015;10(3):e0122034.
13.
MuellerNWhyattRHoepnerL, et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes. 2014;39(4):665-670.
14.
DierikxTHVisserDHBenningaMA, et al. The influence of prenatal and intrapartum antibiotics on intestinal microbiota colonisation in infants: a systematic review. J Infect. 2020;81(2):190-204.
15.
BruelHGuillemantVSaladin-ThironCChabrolleJPLaharyAPoinsotJ. Anémie hémolytique chez un nouveau-né après prise maternelle de nitrofurantoïne en fin de grossesse [Hemolytic anaemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy]. Arch Pediatr. 2000;7(7):745-747.
16.
VítekLZelenkaJZadinováMMalinaJ. The impact of intestinal microflora on serum bilirubin levels. J Hepatol. 2005;42(2):238-243.
17.
TiribelliCOstrowJD. Intestinal flora and bilirubin. J Hepatol. 2005;42(2):170-172.
18.
ChenKYuanT. The role of microbiota in neonatal hyperbilirubinaemia. Am J Transl Res. 2020;12(11):7459-7474.
19.
DongTChenTWhiteR, et al. Meconium microbiome associates with the development of neonatal jaundice. Clin Transl Gastroenterol. 2018;9(9):182.
20.
MutluMAslanYKaderŞAktürk AcarF. Preventive effects of probiotic supplementation on neonatal hyperbilirubinaemia caused by isoimmunization. Am J Perinatol. 2019;37(11):1173-1176.
21.
Zahed PashaYAhmadpour-KachoMAhmadi JaziAGholiniaH. Effect of probiotics on serum bilirubin level in term neonates with jaundice; a randomized clinical trial. Int J Pediatr. 2017;5(10):5953-5958.
22.
ChenZZhangLZengL, et al. Probiotics supplementation therapy for pathological neonatal jaundice: a systematic review and meta-analysis. Front Pharmacol. 2017;8:432.
23.
LiHXiaoBZhangYXiaoSLuoJHuangW. Impact of maternal intrapartum antibiotics on the initial oral microbiome of neonates. Pediatr Neonatol. 2019;60(6):654-661.
24.
Gomez-ArangoLBarrettHMcIntyreHCallawayLMorrisonMDekker NitertM. Antibiotic treatment at delivery shapes the initial oral microbiome in neonates. Sci Rep. 2017;7:43481.
25.
HulzebosCVDijkPH. Bilirubin-albumin binding, bilirubin/albumin ratios, and free bilirubin levels: where do we stand?Semin Perinatol. 2014;38(7):412-421.
26.
WadsworthSJSuhB. In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns. Antimicrob Agents Chemother. 1988;32(10):1571-1575.
27.
FinkSKarpWRobertsonA. Ceftriaxone effect on bilirubin-albumin binding. Pediatrics. 1987;80(6):873-875.
28.
RobertsonAFinkSKarpW. Effect of cephalosporins on bilirubin-albumin binding. J Pediatr. 1988;112(2):291-294.
29.
BrodersenREbbesenF. Bilirubin-displacing effect of ampicillin, indomethacin, chlorpromazine, gentamicin, and parabens in vitro and in newborn infants. J Pharm Sci. 1983;72(3):248-253.
30.
BhutaniVJohnsonLSivieriE. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinaemia in healthy term and near-term newborns. Pediatrics. 1999;103(1):6-14.
